Compare UFG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFG | HBIO |
|---|---|---|
| Founded | 2021 | 1901 |
| Country | Singapore | United States |
| Employees | 26 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6M | 26.5M |
| IPO Year | N/A | 2000 |
| Metric | UFG | HBIO |
|---|---|---|
| Price | $0.72 | $6.00 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 98.4K | 12.7K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | $3.95 | $4.77 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | $211.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $0.38 |
| 52 Week High | $9.91 | $7.50 |
| Indicator | UFG | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 47.55 |
| Support Level | $0.64 | $5.91 |
| Resistance Level | $0.88 | $6.70 |
| Average True Range (ATR) | 0.07 | 0.28 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 49.02 | 12.20 |
Uni-Fuels Holdings Ltd is a service provider of marine fuel solutions. It operates on an integrated business model, serving customers through two operating models: sales of marine fuels solutions and brokerage (i.e., acting as an intermediary between marine fuels suppliers and customers for a commission). The various marine fuel products offered by the company include very low sulfur fuel oil, high sulfur fuel oil, marine gas oil, and bio marine fuel. Its customers are mainly shipping companies and other fuel suppliers operating in market sectors such as bulk, tanker, offshore, container, general cargo, tug and barge, car carrier, cruise, yacht, and dredging. Geographically, the company derives maximum revenue from Singapore, and the rest from Malaysia, Hong Kong, China, and other regions.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.